Search results
His discovery saved millions, yet he was never paid a single cent. Thus sums up the sad story of Abelardo Aguilar, the Filipino physician who helped discover erythromycin and made his employer filthy rich yet was never duly compensated nor recognized for his efforts.
Abelardo Aguilar (November 3, 1917 – September 22, 1993 was a Filipino doctor from Iloilo, Philippines who worked as a medical representative for Eli Lilly and Company. Discovery of Erythromycin
Apr 20, 2020 · A drug representative for U.S. pharmaceutical company Eli Lilly and Company, Aguilar was studying samples he obtained from a Molo cemetery (some accounts refer to it as “his own backyard”) and stumbled upon a species of bacteria called 𝘚𝘢𝘤𝘤𝘩𝘢𝘳𝘰𝘱𝘰𝘭𝘺𝘴𝘱𝘰𝘳𝘢 𝘦𝘳𝘺𝘵𝘩𝘳𝘢𝘦𝘢 (formerly 𝘚𝘵𝘳𝘦𝘱𝘵𝘰𝘮𝘺𝘤𝘦𝘴 𝘦𝘳𝘺𝘵𝘩𝘳𝘢𝘦𝘶𝘴).
May 3, 2005 · The man was Dr. Abelardo B. Aguilar, an Ilonggo physician and then medical representative of American-firm, Eli Lilly and Company. Assigned by said company with code number 12559, Dr. Aguilar's discovery was among the thousands of soil samples sent for testing.
In 1949 Abelardo B. Aguilar, a Filipino scientist, sent some soil samples to his employer at Eli Lilly. Aguilar managed to isolate erythromycin from the metabolic products of a strain of Streptomyces erythreus (designation changed to Saccharopolyspora erythraea) found in the samples.
Nov 9, 1994 · In 1949, Filipino doctor Abelardo Aguilar was testing micro-organisms he had isolated when he chanced upon bacteria that would later lead to the development of the antibiotic erythromycin.
Oct 4, 2019 · A doctor from Iloilo, Abelardo Aguilar, worked for the pharmaceutical company Eli Lilly and Company as a researcher. Then in 1949, he submitted samples of his work to the company’s research team. In 1952, it was declared that a new kind of antibiotic was discovered.
